DK477783D0 - 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler - Google Patents

1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler

Info

Publication number
DK477783D0
DK477783D0 DK4777/83A DK477783A DK477783D0 DK 477783 D0 DK477783 D0 DK 477783D0 DK 4777/83 A DK4777/83 A DK 4777/83A DK 477783 A DK477783 A DK 477783A DK 477783 D0 DK477783 D0 DK 477783D0
Authority
DK
Denmark
Prior art keywords
aryl
isoquinolines
pyrazino
hexahydro
intermediates
Prior art date
Application number
DK4777/83A
Other languages
English (en)
Other versions
DK477783A (da
Inventor
Ronald C Griffith
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK477783D0 publication Critical patent/DK477783D0/da
Publication of DK477783A publication Critical patent/DK477783A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK477783A 1982-10-18 1983-10-17 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmaade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler DK477783A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/435,132 US4517187A (en) 1982-10-18 1982-10-18 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants

Publications (2)

Publication Number Publication Date
DK477783D0 true DK477783D0 (da) 1983-10-17
DK477783A DK477783A (da) 1984-04-19

Family

ID=23727113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK477783A DK477783A (da) 1982-10-18 1983-10-17 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmaade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler

Country Status (14)

Country Link
US (1) US4517187A (da)
EP (1) EP0107825B1 (da)
JP (1) JPS5989680A (da)
KR (1) KR870000622B1 (da)
AT (1) ATE32720T1 (da)
AU (1) AU1955583A (da)
CA (1) CA1219874A (da)
DE (1) DE3375784D1 (da)
DK (1) DK477783A (da)
FI (1) FI833784A (da)
IL (1) IL69586A (da)
NO (1) NO833778L (da)
NZ (1) NZ205425A (da)
ZA (1) ZA836448B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782058A (en) * 1985-04-26 1988-11-01 Pennwalt Corporation 1,3,4,6,7,11b-Hexahydro-6-phenyl-2H-pyrazino-(2,1-a)isoquinolines, for anti-histamine or anti-depression treatment
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression
US4772705A (en) * 1985-07-25 1988-09-20 Pennwalt Corporation Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
DE69524241T2 (de) * 1994-09-30 2002-06-13 Pfizer Inc., New York 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate
EP3186250B1 (en) * 2014-08-27 2018-04-18 F.Hoffmann-La Roche Ag Substituted pyrazino[2,1-a]isoquinoline derivatives for the treatment of cns disorders
MX2022004739A (es) * 2019-10-31 2022-07-19 Holosmedic Compuesto novedoso y composicion farmaceutica para prevencion o tratamiento de cancer que comprende el mismo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050901A (da) * 1964-02-06
US3684813A (en) * 1970-04-08 1972-08-15 Sterling Drug Inc Hexahydropyrazinoisoquinolines
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0107825A1 (en) 1984-05-09
IL69586A0 (en) 1983-11-30
CA1219874A (en) 1987-03-31
KR840006656A (ko) 1984-12-01
ATE32720T1 (de) 1988-03-15
JPS5989680A (ja) 1984-05-23
FI833784A0 (fi) 1983-10-17
DK477783A (da) 1984-04-19
IL69586A (en) 1986-07-31
NZ205425A (en) 1986-05-09
NO833778L (no) 1984-04-24
KR870000622B1 (ko) 1987-03-26
DE3375784D1 (en) 1988-04-07
US4517187A (en) 1985-05-14
FI833784A (fi) 1984-04-19
ZA836448B (en) 1984-07-25
EP0107825B1 (en) 1988-03-02
AU1955583A (en) 1984-05-03

Similar Documents

Publication Publication Date Title
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
KR870700613A (ko) 신규 벤조티아진 유도체
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK477783D0 (da) 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler
FR2508033B1 (da)
DK421586A (da) Irreversible dopamin-beta-hydroxylaseinhibitorer
ES522418A0 (es) Un procedimiento para preparar -15-desoxiespergualina.
NO20000423D0 (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
ES2131015B1 (es) Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
ATE52776T1 (de) 1-phenyl-3-benzazepine.
AR004696A1 (es) Derivados de amidina e isotiourea, procedimientos para su preparacion, intermediarios nuevos utiles en dicho procedimiento, composiciones que loscontienen, su uso en terapia y metodos de tratamiento que comprenden dicho compuesto

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment